Literature DB >> 15256190

Severity of depressive symptoms, hippocampal sclerosis, auditory memory, and side of seizure focus in temporal lobe epilepsy.

Mario F Dulay1, Bruce K Schefft, Jamison D Fargo, Michael D Privitera, Hwa-Shain Yeh.   

Abstract

The relationship between severity of depressive symptoms and performance on three Wechsler Memory Scale-III auditory memory and learning subtests was examined in 84 inpatients diagnosed with medically intractable seizures of left (n=46, LTLE) or right (n=38, RTLE) temporal lobe origin. Depressive symptom severity was associated with auditory recall test performance in individuals with LTLE, but not RTLE. Multiple regression analyses indicated that severity of depressive symptoms, hippocampal sclerosis, and naming ability were significant predictors of auditory memory test performance in LTLE; however, hippocampal sclerosis was the only significant predictor of auditory memory in RTLE. Results demonstrate the importance of hippocampal sclerosis, greater self-report of depressive symptoms, and poor naming ability as independent predictors of poor auditory memory and learning abilities. Results suggest that a complex relationship exists among multiple risk factors that combine to influence performance on auditory memory tests as a function of side of seizure focus.

Entities:  

Mesh:

Year:  2004        PMID: 15256190     DOI: 10.1016/j.yebeh.2004.04.007

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  10 in total

Review 1.  Current Concepts of Memory Disorder in Epilepsy: Edging Towards a Network Account.

Authors:  Genevieve Rayner; Chris Tailby
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

2.  Mechanisms of memory impairment in epilepsy depend on age at disease onset.

Authors:  Genevieve Rayner; Graeme D Jackson; Sarah J Wilson
Journal:  Neurology       Date:  2016-09-16       Impact factor: 9.910

3.  WMS-III Logical Memory performance after a two-week delay in temporal lobe epilepsy and control groups.

Authors:  Brian D Bell
Journal:  J Clin Exp Neuropsychol       Date:  2006-11       Impact factor: 2.475

4.  Different structural correlates for verbal memory impairment in temporal lobe epilepsy with and without mesial temporal lobe sclerosis.

Authors:  Susanne G Mueller; Kenneth D Laxer; Cathy Scanlon; Paul Garcia; William J McMullen; David W Loring; Kimford J Meador; Michael W Weiner
Journal:  Hum Brain Mapp       Date:  2011-03-24       Impact factor: 5.038

5.  Effects of surgical side and site on mood and behavior outcome in children with pharmacoresistant epilepsy.

Authors:  Elizabeth N Andresen; Maya J Ramirez; Kevin H Kim; Ava B Dorfman; Jennifer S Haut; Patricia A Klaas; Lara E Jehi; Katherine Shea; William E Bingaman; Robyn M Busch
Journal:  Front Neurol       Date:  2014-02-19       Impact factor: 4.003

6.  Depressive disorders in patients with pharmaco-resistant mesial temporal lobe epilepsy.

Authors:  Eleonora Borges Gonçalves; Tania Aparecida Marchiori de Oliveira Cardoso; Clarissa Lin Yasuda; Fernando Cendes
Journal:  J Int Med Res       Date:  2017-09-27       Impact factor: 1.671

7.  Focal impaired awareness seizures in a rodent model: A functional anatomy.

Authors:  Nadia Adotevi; Jaideep Kapur
Journal:  Epilepsia Open       Date:  2021-12-17

8.  Non-verbal auditory cognition in patients with temporal epilepsy before and after anterior temporal lobectomy.

Authors:  Aurelie Bidet-Caulet; Xiao Lai Ye; Patrick Bouchet; Marc Guénot; Catherine Fischer; Olivier Bertrand
Journal:  Front Hum Neurosci       Date:  2009-11-30       Impact factor: 3.169

9.  Depression in temporal lobe epilepsy: a review of prevalence, clinical features, and management considerations.

Authors:  C S Garcia
Journal:  Epilepsy Res Treat       Date:  2011-12-01

Review 10.  The Most Common Lesions Detected by Neuroimaging as Causes of Epilepsy.

Authors:  Bożena Adamczyk; Karolina Węgrzyn; Tomasz Wilczyński; Justyna Maciarz; Natalia Morawiec; Monika Adamczyk-Sowa
Journal:  Medicina (Kaunas)       Date:  2021-03-22       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.